St. Jude Children’s Research Hospital has named James Morgan, Ph.D., scientific director and an executive vice president. Morgan held the interim scientific director post since 2015, and was formerly chair of the Department of Developmental Neurobiology.
As scientific director, Morgan will oversee the institution’s basic science programs and related research efforts. The appointment comes as St. Jude takes steps to strengthen its basic research programs to advance the fight against childhood cancer and other life-threatening diseases.
“Under Dr. Morgan’s direction, the Department of Developmental Neurobiology has earned a world-class reputation for cutting-edge basic science,” said James R. Downing, M.D., St. Jude president and chief executive officer. “His scientific expertise and leadership experience will be invaluable in leading efforts to research and find cures for pediatric catastrophic diseases.”
Morgan joined St. Jude in 1995 as a full member and co-chair of the newly formed Department of Developmental Neurobiology. He became the department’s chair in 2006, guiding Developmental Neurobiology as it became renowned for investigating fundamental aspects of nervous system function and developing novel clinical therapies.
He earned a doctorate from the University of Aston in Birmingham, England, and trained as a postdoctoral fellow at the Max Planck Institute in Tubingen, Germany. Following training, Morgan joined the Roche Institute of Molecular Biology in Nutley, New Jersey, before coming to St. Jude. He holds the Shahdam, Edna and Albert Abdo Basic Science Chair.
Last updated on: 27/08/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.